CEACAM-7 hFc Chimera, Human
CEACAM-7 HFc Chimera, Human

Immobilized CEACAM-7 hFc Chimera, Human, His Tag at 2 μg/ml (100 μI/well) on the plate. Dose response curve for Human CEACAM-7, hFc Tag with the EC50 of 25.2ng/ml determined by ELISA.

CEACAM-7 HFc Chimera, Human

The purity of CEACAM-7 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

CEACAM-7 HFc Chimera, Human

CEACAM-7 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

CEACAM-7 hFc Chimera, Human

Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) belong to a group of mammalian immunoglobulin-related glycoproteins. They are involved in cell–cell recognition and modulate cellular processes that range from the shaping of tissue architecture and neovascularization to the regulation of insulin homeostasis and T-cell proliferation. CEACAM7 (CGM2), a member of the CEA family of proteins with expression restricted to the colon and pancreas, as a potential CAR T-cell target for PDAC.
Z05164
¥63,425.00

Ask us a question
Product Introduction
Species Human
Protein Construction
CEACAM-7 (Thr36-Ser242)
Accession # Q14002-1		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 50.11 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 68-78 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • CEACAM-7 HFc Chimera, Human
    • CEACAM-7 HFc Chimera, Human

    Immobilized CEACAM-7 hFc Chimera, Human, His Tag at 2 μg/ml (100 μI/well) on the plate. Dose response curve for Human CEACAM-7, hFc Tag with the EC50 of 25.2ng/ml determined by ELISA.

  • CEACAM-7 HFc Chimera, Human
    • CEACAM-7 HFc Chimera, Human

    The purity of CEACAM-7 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

  • CEACAM-7 HFc Chimera, Human
    • CEACAM-7 HFc Chimera, Human

    CEACAM-7 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) belong to a group of mammalian immunoglobulin-related glycoproteins. They are involved in cell–cell recognition and modulate cellular processes that range from the shaping of tissue architecture and neovascularization to the regulation of insulin homeostasis and T-cell proliferation. CEACAM7 (CGM2), a member of the CEA family of proteins with expression restricted to the colon and pancreas, as a potential CAR T-cell target for PDAC.
Synonyms CGM2; CEACAM7; CEA

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.